Wedelolactone Attenuates Pulmonary Fibrosis Partly Through Activating AMPK and Regulating Raf-MAPKs Signaling Pathway.

Name: Wedelolactone Attenuates Pulmonary Fibrosis Partly Through Activating AMPK and Regulating Raf-MAPKs Signaling Pathway.
Author: Yang, Jin-Yu

Wedelolactone Attenuates Pulmonary Fibrosis Partly Through Activating AMPK and Regulating Raf-MAPKs Signaling Pathway. — المؤلف: Yang, Jin-Yu — Frontiers in pharmacology 2019

المؤلف: Yang, Jin-Yu
النشر: Frontiers in pharmacology 2019
الوصف: 151 p.